SE0300627D0 - Novel fused heterocycles and uses therof - Google Patents

Novel fused heterocycles and uses therof

Info

Publication number
SE0300627D0
SE0300627D0 SE0300627A SE0300627A SE0300627D0 SE 0300627 D0 SE0300627 D0 SE 0300627D0 SE 0300627 A SE0300627 A SE 0300627A SE 0300627 A SE0300627 A SE 0300627A SE 0300627 D0 SE0300627 D0 SE 0300627D0
Authority
SE
Sweden
Prior art keywords
fused heterocycles
novel fused
uses therof
therof
novel
Prior art date
Application number
SE0300627A
Other languages
Swedish (sv)
Inventor
Robert Jacobs
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0300627A priority Critical patent/SE0300627D0/en
Publication of SE0300627D0 publication Critical patent/SE0300627D0/en
Priority to KR1020057016722A priority patent/KR20050107784A/en
Priority to PT04717339T priority patent/PT1601673E/en
Priority to US10/548,138 priority patent/US20060270689A1/en
Priority to EP04717339A priority patent/EP1601673B1/en
Priority to ES04717339T priority patent/ES2326647T3/en
Priority to RU2005130934/04A priority patent/RU2374251C2/en
Priority to SI200431186T priority patent/SI1601673T1/en
Priority to BRPI0408150-1A priority patent/BRPI0408150A/en
Priority to PL04717339T priority patent/PL1601673T3/en
Priority to PCT/SE2004/000304 priority patent/WO2004078758A1/en
Priority to MYPI20040755A priority patent/MY141583A/en
Priority to JP2006507939A priority patent/JP3947758B2/en
Priority to AT04717339T priority patent/ATE433448T1/en
Priority to MXPA05009577A priority patent/MXPA05009577A/en
Priority to CN200480011766.4A priority patent/CN1780835B/en
Priority to DK04717339T priority patent/DK1601673T3/en
Priority to DE602004021477T priority patent/DE602004021477D1/en
Priority to AU2004218080A priority patent/AU2004218080B2/en
Priority to NZ542227A priority patent/NZ542227A/en
Priority to CA2518224A priority patent/CA2518224C/en
Priority to ARP040100701A priority patent/AR043487A1/en
Priority to TW093105906A priority patent/TW200510427A/en
Priority to UAA200509430A priority patent/UA81470C2/en
Priority to PCT/GB2005/003207 priority patent/WO2006018628A1/en
Priority to ARP050103460A priority patent/AR050920A1/en
Priority to US11/207,089 priority patent/US20060063751A1/en
Priority to ZA200507361A priority patent/ZA200507361B/en
Priority to IS8036A priority patent/IS8036A/en
Priority to NO20054340A priority patent/NO20054340L/en
Priority to HK06104612.4A priority patent/HK1084390A1/en
Priority to JP2006201461A priority patent/JP2007063257A/en
Priority to US12/032,438 priority patent/US20080153854A1/en
Priority to CY20091100845T priority patent/CY1109300T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention relates to a compound with the following formula (I) and drug composition and a use process. The novel compound can be used to cure or prevent cancers, wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined in the specification of the invention.
SE0300627A 2003-03-07 2003-03-07 Novel fused heterocycles and uses therof SE0300627D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE0300627A SE0300627D0 (en) 2003-03-07 2003-03-07 Novel fused heterocycles and uses therof
CA2518224A CA2518224C (en) 2003-03-07 2004-03-04 Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
DK04717339T DK1601673T3 (en) 2003-03-07 2004-03-04 Condensed heterocycles and their applications
AU2004218080A AU2004218080B2 (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof
US10/548,138 US20060270689A1 (en) 2003-03-07 2004-03-04 Novel Fused Heterocycles and Uses Thereof
DE602004021477T DE602004021477D1 (en) 2003-03-07 2004-03-04 CONDENSED HETEROCYCLES AND ITS USES
ES04717339T ES2326647T3 (en) 2003-03-07 2004-03-04 CONDENSED HETEROCICLES AND ITS USES.
RU2005130934/04A RU2374251C2 (en) 2003-03-07 2004-03-04 New condensed heterocyclic compounds and their use
SI200431186T SI1601673T1 (en) 2003-03-07 2004-03-04 Fused heterocycles and uses thereof
PT04717339T PT1601673E (en) 2003-03-07 2004-03-04 Fused heterocycles and uses thereof
PL04717339T PL1601673T3 (en) 2003-03-07 2004-03-04 Fused heterocycles and uses thereof
PCT/SE2004/000304 WO2004078758A1 (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof
MYPI20040755A MY141583A (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof
JP2006507939A JP3947758B2 (en) 2003-03-07 2004-03-04 Novel condensed heterocycles and their use
AT04717339T ATE433448T1 (en) 2003-03-07 2004-03-04 CONDENSED HETEROCYCLES AND USES THEREOF
NZ542227A NZ542227A (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof
CN200480011766.4A CN1780835B (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof
KR1020057016722A KR20050107784A (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof
EP04717339A EP1601673B1 (en) 2003-03-07 2004-03-04 Fused heterocycles and uses thereof
BRPI0408150-1A BRPI0408150A (en) 2003-03-07 2004-03-04 compound, its use and process for its preparation, methods for cancer treatment or prophylaxis and for producing a cell cycle inhibitory effect (anti - cell proliferation) in a warm blooded animal and pharmaceutical composition
MXPA05009577A MXPA05009577A (en) 2003-03-07 2004-03-04 Novel fused heterocycles and uses thereof.
ARP040100701A AR043487A1 (en) 2003-03-07 2004-03-05 FUSIONED HEREROCICLES OF PYRIMIDINE AND USES OF THE SAME
TW093105906A TW200510427A (en) 2003-03-07 2004-03-05 Novel fused heterocycles and uses thereof
UAA200509430A UA81470C2 (en) 2003-03-07 2004-04-03 Fused heterocycles and uses thereof
PCT/GB2005/003207 WO2006018628A1 (en) 2003-03-07 2005-08-16 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
ARP050103460A AR050920A1 (en) 2003-03-07 2005-08-16 ENANTIOMERS OF SELECTED FUSED HETEROCICLES AND USES OF THE SAME
US11/207,089 US20060063751A1 (en) 2003-03-07 2005-08-18 Novel fused heterocycles and uses thereof
ZA200507361A ZA200507361B (en) 2003-03-07 2005-09-13 Novel fused heterocycles and uses thereof
IS8036A IS8036A (en) 2003-03-07 2005-09-19 New woven heterocycles and their use
NO20054340A NO20054340L (en) 2003-03-07 2005-09-20 New interconnected heterocycles and their use
HK06104612.4A HK1084390A1 (en) 2003-03-07 2006-04-18 Fused heterocycles and uses thereof
JP2006201461A JP2007063257A (en) 2003-03-07 2006-07-25 New fused heterocycle and use of the same
US12/032,438 US20080153854A1 (en) 2003-03-07 2008-02-15 Novel fused heterocycles and uses thereof
CY20091100845T CY1109300T1 (en) 2003-03-07 2009-08-10 New Co-ordinated Heterocyclic Rings and Their Uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300627A SE0300627D0 (en) 2003-03-07 2003-03-07 Novel fused heterocycles and uses therof

Publications (1)

Publication Number Publication Date
SE0300627D0 true SE0300627D0 (en) 2003-03-07

Family

ID=20290609

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300627A SE0300627D0 (en) 2003-03-07 2003-03-07 Novel fused heterocycles and uses therof

Country Status (3)

Country Link
CN (1) CN1780835B (en)
SE (1) SE0300627D0 (en)
ZA (1) ZA200507361B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
EP1343505A1 (en) * 2000-12-11 2003-09-17 Tularik Inc. Cxcr3 antagonists

Also Published As

Publication number Publication date
CN1780835A (en) 2006-05-31
CN1780835B (en) 2010-06-09
ZA200507361B (en) 2007-01-31

Similar Documents

Publication Publication Date Title
ATE524476T1 (en) PYRAZOLOPYRIMIDINES AS MODULATORS OF CASEINKINASE II (CK2)
GEP20084505B (en) 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
TW200617009A (en) Organic compounds
UY29041A1 (en) DERIVATIVES OF AMINO-PIPERIDINE, ITS PREPARATION AND ITS USE IN THERAPEUTICS
TW200745032A (en) Novel heterobicyclic derivatives
PE20080928A1 (en) ANILINOPIPERAZINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
MY149705A (en) Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
MX2007000505A (en) Substituted oxindol derivatives and medicaments containing the same.
CY1110419T1 (en) Tricyclic compounds based on 1,6-dihydro-1,3,5,6-TETPAAZA-AS-INDAKENE and PHARMACEUTICAL COMPOSITIONS CONTAINING AS INCORRECT
ATE547395T1 (en) AMINOPROPANOL DERIVATIVES AS MODULATORS OF THE SPHINGOSINE-1 PHOSPHATE RECEPTOR
ATE433981T1 (en) HETEROCYCLIC COMPOUNDS
ATE431333T1 (en) AMINO PROPANE DERIVATIVES
DE60322877D1 (en) TETRAHYDROPYRANYLCYCLOPENTYLTETRAHYDROISOCHINO LINMODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
ATE553106T1 (en) HETEROARYLPYRROLOPYRIDINONES AS KINASE INHIBITORS
ATE449069T1 (en) AMINOPROPANOL DERIVATIVES
SE0401762D0 (en) Novel compounds
MXPA05007115A (en) Novel cb 1 receptor inverse agonists.
TW200740781A (en) Novel compounds
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
SE0303541D0 (en) New compounds
TW200609224A (en) Organic compounds
IN2012DN01232A (en)
SE0300092D0 (en) Novel compounds
CY1111432T1 (en) Tetrahydroquinolines for use as modulators of the kinetic protein kinetic EG5